NEW YORK--(BUSINESS WIRE)--Moody's Corporation (NYSE: MCO) announced today that Stephen Tulenko, President of Moody's Analytics, will speak at the Oppenheimer Annual Technology, Internet and Communica
NEW YORK , July 26, 2024 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE: OPY) (the "Company" or "Firm") today reported net income of $10.3 million or $0.99 basic earnings per share for the second quar
Strategic Recruitment of 10 New Hires Builds on Oppenheimer's Momentum as the Credit Landscape and Macroeconomic Trends Signal Greater Demand for Leveraged Finance NEW YORK , July 15, 2024 /PRNewswire
Expanding the Depth and Breadth of Oppenheimer's Biotech Equity Research NEW YORK , July 11, 2024 /PRNewswire/ -- Oppenheimer & Co. Inc. (Oppenheimer) — a leading investment bank, wealth manager, a

5 Best Short-Term Stocks to Consider Investing In

09:01am, Wednesday, 10'th Jul 2024
Not every investor is in the market for the long haul. Some prefer short time frames and volatile stocks, looking to make a profit in days or weeks rather than years.
Kumar Brings Extensive Financial Services Experience to Lead a Four-Person Team that Reflects Oppenheimer Research's Commitment to FinTech and Payments NEW YORK , July 9, 2024 /PRNewswire/ -- Oppenhe
Bhatia's Addition Exemplifies Continued Deployment of Resources  Towards Building a Leading Life Sciences Practice NEW YORK , June 24, 2024 /PRNewswire/ -- Oppenheimer & Co. Inc. (Oppenheimer) — a
Brian Nagel, Oppenheimer senior equity research analyst, joins 'Squawk on the Street' to discuss his thoughts on Nike, where most of his concerns come from with Nike, and much more.
TEL AVIV, Israel, June 20, 2024 (GLOBE NEWSWIRE) -- via IBN –- HUB Cyber Security Ltd. (NASDAQ: HUBC), a developer of confidential computing cybersecurity solutions and advanced data services, today
MOORESVILLE, N.C. , June 19, 2024 /PRNewswire/ -- Lowe's Companies, Inc. (NYSE: LOW) announces that Marvin R.
REDWOOD CITY, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy targe
WAYNE, Pa. and ROCKVILLE, Md., June 17, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) announced today that Garry A. Neil, M.D., Chief Executive Officer and Chairman of the Board, wi

Oppenheimer raises Nvidia price target to $150

11:00am, Tuesday, 11'th Jun 2024
Oppenheimer has raised Nvidia's (NVDA) price target to $150 from $110 following its 10-for-1 stock split. Yahoo Finance's Alexandra Canal and Brad Smith report more on the call and the tailwinds ahead
TARRYTOWN, N.Y., June 06, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference on M
PHILADELPHIA, PA, June 06, 2024 (GLOBE NEWSWIRE) -- Five Below, Inc. (NASDAQ: FIVE), the trend-right, high-quality extreme-value retailer for tweens, teens and beyond, today announced that management
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE